Related Experiment Video
Updated: May 6, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
28.4K
Heart failure induced by itraconazole.
1Department of Cardiology, Sakarya Education and Research Hospital, Adapazari, Sakarya, Turkey.
Indian Journal of Pharmacology
|October 17, 2013
Summary
Itraconazole, an antifungal drug, can rarely cause heart failure. This case study details a 60-year-old woman who developed heart failure after taking itraconazole.
Area of Science:
- Pharmacology
- Cardiology
- Toxicology
Background:
- Itraconazole is a widely used broad-spectrum antifungal medication.
- Cardiovascular adverse effects are uncommon with itraconazole use.
- Heart failure is a rare but serious potential side effect.
Observation:
- A 60-year-old female patient was treated with itraconazole.
- The patient subsequently developed symptoms indicative of heart failure.
Findings:
- The patient's heart failure was determined to be induced by itraconazole.
- This case highlights a rare adverse reaction to itraconazole.
Implications:
- Clinicians should be aware of the potential for itraconazole-induced heart failure.
- Monitoring cardiovascular health in patients on itraconazole may be warranted.
- Further research into itraconazole's cardiotoxicity is needed.
More Related Videos
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
01:26Heart Failure III: Clinical Manifestations
1.5K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.5K
01:22Heart Failure Drugs: β-Blockers
3.0K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
3.0K
01:27Heart Failure I: Introduction
2.1K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2.1K
01:29Heart Failure II: Pathophysiology
2.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K